R&D Overview

How we choose what to make available

Sanveex is a marketing and distribution company rather than a research laboratory. Our product development work therefore focuses on identifying molecules that already have a strong evidence base but remain under-served or inconsistently available in Bangladesh.

Our selection framework

• Unmet clinical need — where does local prescriber demand outstrip reliable supply?
• Evidence quality — is there peer-reviewed, guideline-level support for the indication?
• Manufacturing feasibility — can the product be produced to WHO-GMP standard at a sustainable cost?
• Regulatory pathway — is a clear and achievable registration route available with the DGDA?
• Commercial viability — can it be delivered at a price clinicians and patients can accept?

From decision to launch

A validated molecule moves through dossier preparation, stability and bioequivalence requirements where applicable, artwork development for Bengali and English labelling, DGDA submission and approval. Only after authorisation is granted does commercial launch planning begin — including prescriber education, distributor briefing and pharmacovigilance preparation.